In this context, a study among Japanese subjects showed that TT and CT genotypes at −45 locus in the promoter region of the CCK gene have been associated with higher frequency of hallucinations in levodopa-treated PD patients [129]. The gene discussed is CCK; the disease is Parkinson disease.